358 related articles for article (PubMed ID: 34681646)
1. Recent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases.
Schreurs J; Sacchetto C; Colpaert RMW; Vitiello L; Rampazzo A; Calore M
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681646
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
3. Engineering of Zinc Finger Nucleases Through Structural Modeling Improves Genome Editing Efficiency in Cells.
Katayama S; Watanabe M; Kato Y; Nomura W; Yamamoto T
Adv Sci (Weinh); 2024 Jun; 11(23):e2310255. PubMed ID: 38600709
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
5. Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals.
Wani AK; Akhtar N; Singh R; Prakash A; Raza SHA; Cavalu S; Chopra C; Madkour M; Elolimy A; Hashem NM
Vet Res Commun; 2023 Jan; 47(1):1-16. PubMed ID: 35781172
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.
Rasoulinejad SA; Maroufi F
Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656
[TBL] [Abstract][Full Text] [Related]
7. The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges.
Eş I; Gavahian M; Marti-Quijal FJ; Lorenzo JM; Mousavi Khaneghah A; Tsatsanis C; Kampranis SC; Barba FJ
Biotechnol Adv; 2019; 37(3):410-421. PubMed ID: 30779952
[TBL] [Abstract][Full Text] [Related]
8. Gene editing and CRISPR in the clinic: current and future perspectives.
Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
[TBL] [Abstract][Full Text] [Related]
9. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Genome Editing as a Therapeutic Approach.
Ho BX; Loh SJH; Chan WK; Soh BS
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213032
[TBL] [Abstract][Full Text] [Related]
11. A beginner's guide to gene editing.
Harrison PT; Hart S
Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
Batzir NA; Tovin A; Hendel A
Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus.
Gutierrez-Guerrero A; Sanchez-Hernandez S; Galvani G; Pinedo-Gomez J; Martin-Guerra R; Sanchez-Gilabert A; Aguilar-González A; Cobo M; Gregory P; Holmes M; Benabdellah K; Martin F
Hum Gene Ther; 2018 Mar; 29(3):366-380. PubMed ID: 28922955
[TBL] [Abstract][Full Text] [Related]
15. Genome editing: An insight into disease resistance, production efficiency, and biomedical applications in livestock.
Yuan YG; Liu SZ; Farhab M; Lv MY; Zhang T; Cao SX
Funct Integr Genomics; 2024 May; 24(3):81. PubMed ID: 38709433
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9: An RNA-guided highly precise synthetic tool for plant genome editing.
Demirci Y; Zhang B; Unver T
J Cell Physiol; 2018 Mar; 233(3):1844-1859. PubMed ID: 28430356
[TBL] [Abstract][Full Text] [Related]
17. Construction and Evaluation of Zinc Finger Nucleases.
Ochiai H; Yamamoto T
Methods Mol Biol; 2023; 2637():1-25. PubMed ID: 36773134
[TBL] [Abstract][Full Text] [Related]
18. Application of CRISPR-Mediated Gene Editing for Crop Improvement.
Negi C; Vasistha NK; Singh D; Vyas P; Dhaliwal HS
Mol Biotechnol; 2022 Nov; 64(11):1198-1217. PubMed ID: 35672603
[TBL] [Abstract][Full Text] [Related]
19. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
Naeem M; Majeed S; Hoque MZ; Ahmad I
Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
[TBL] [Abstract][Full Text] [Related]
20. Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases.
Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL
Neurochem Int; 2018 Jan; 112():187-196. PubMed ID: 28732771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]